Status:
WITHDRAWN
Intradetrusor Botox at the Time of Transurethral Resection of the Prostate for Mixed Lower Urinary Tract Symptoms
Lead Sponsor:
Benaroya Research Institute
Conditions:
Transurethral Resection of the Prostate
Eligibility:
MALE
18+ years
Brief Summary
Patients with longstanding obstructive lower urinary tract symptoms (LUTS) due to benign prostatic hypertrophy (BPH) can also develop symptoms of overactive bladder syndrome (OAB). Transurethral resec...
Detailed Description
An observational study of the effect of Botox injection at the time of TURP will be performed. If deemed eligible, participants will be invited to participate in this trial. The International Prostat...
Eligibility Criteria
Inclusion
- Male ≥ 18 years of age, and being scheduled to undergo TURP and Botox procedure.
- Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.
Exclusion
- Non-English Speaking
- Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
- History of receiving Botox in the bladder, within the previous 12 months.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2026
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06531655
Start Date
August 1 2024
End Date
August 1 2026
Last Update
August 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virginia Mason Medical Center
Seattle, Washington, United States, 98101